Skip to main content
Episurf logo

Episurf — Investor Relations & Filings

Ticker · EPIS ISIN · SE0003491562 LEI · 549300GORBCSMHZB2J75 ST Manufacturing
Open in API
Filings indexed 872 across all filing types
Latest filing 2026-04-02 Capital/Financing Update
Country SE Sweden
Listing ST EPIS

About Episurf

https://episurf.com/

Episurf is a medical device company that develops and commercializes patient-specific solutions for treating painful joint injuries. The company's core technology utilizes 3D imaging to create personalized orthopedic implants and surgical instruments tailored to each patient's unique anatomy and cartilage defect. Its primary product line, the Episealer® system, provides minimally invasive implants for treating cartilage and underlying bone lesions in the knee and ankle joints. The objective of this individualized approach is to repair the joint, alleviate pain, and restore function, offering a treatment option for patients, often middle-aged, who are not yet candidates for total joint replacement surgery.

Recent filings

Filing Released Lang Actions
Episurf Medical Acquires Property Portfolio with an Agreed Property Value of SEK 697 Million from Mofast AB
Capital/Financing Update Classification · 1% confidence The document is a corporate press release announcing Episurf Medical’s acquisition of a property portfolio and detailing the accompanying financing structure, including issuance of promissory notes, directed share issue, and convertible loans. It focuses on fundraising and capital structure changes to fund the transaction, which aligns with the Capital/Financing Update category.
2026-04-02 English
Episurf Medical förvärvar fastighetsportfölj med ett överenskommet fastighetsvärde om MSEK 697 från Mofast AB
M&A Activity Classification · 1% confidence The document is a transaction announcement detailing Episurf Medical’s acquisition of a real estate portfolio (36 properties) via the purchase of shares in Bolaget XX22 AB and its subsidiaries. It outlines deal terms, purchase consideration (share issuance, convertible loans), dilution effects, and closing conditions. This is a clear M&A activity rather than an earnings release or routine financing notice. Therefore, it should be classified under M&A Activity (TAR).
2026-04-02 Swedish
Annual Report (ESEF) 2025
Annual Report (ESEF) Classification · 1% confidence FY 2025
2026-03-20 Swedish
Annual Report (ESEF) 2025
Annual Report (ESEF) Classification · 1% confidence FY 2025
2026-03-20 Swedish
Kallelse till extra bolagsstämma i Episurf Medical AB (publ)
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a formal 'Kallelse till extra bolagsstämma' (Notice of Extraordinary General Meeting) for Episurf Medical AB. It contains the agenda, proposals for board changes, amendments to the articles of association, and instructions for shareholders to participate or vote by proxy. This document is a classic proxy solicitation and information statement provided to shareholders ahead of a meeting.
2026-03-11 Swedish
Notice of Extraordinary General Meeting of Episurf Medical AB (publ)
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a formal 'Notice of Extraordinary General Meeting' for Episurf Medical AB. It contains the agenda, instructions for voting (in person, proxy, or postal), and detailed proposals regarding share capital amendments and acquisitions to be voted upon by shareholders. This document is a classic proxy solicitation material sent to shareholders to inform them of an upcoming meeting and request their votes on specific corporate actions.
2026-03-11 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.